Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial

BACKGROUND AND PURPOSE: Whether pharmacologically altered high-density lipoprotein cholesterol (HDL-C) affects the risk of cardiovascular events is unknown. Recently, we have reported the Prevention of Cardiovascular Events in Asian Patients with Ischaemic Stroke at High Risk of Cerebral Haemorrhage...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eun-Jae, Kwon, Sun U., Park, Jong-Ho, Kim, Yong-Jae, Hong, Keun-Sik, Yu, Sungwook, Hwang, Yang-Ha, Lee, Ji Sung, Lee, Juneyoung, Rha, Joung-Ho, Heo, Sung Hyuk, Ahn, Sung Hwan, Seo, Woo-Keun, Park, Jong-Moo, Lee, Ju-Hun, Kwon, Jee-Hyun, Sohn, Sung-Il, Jung, Jin-Man, Kim, Hahn Young, Kim, Eung-Gyu, Kim, Sung Hun, Cha, Jae-Kwan, Park, Man-Seok, Nam, Hyo Suk, Kang, Dong-Wha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Stroke Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005357/
https://www.ncbi.nlm.nih.gov/pubmed/32027796
http://dx.doi.org/10.5853/jos.2019.02551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005357/
https://www.ncbi.nlm.nih.gov/pubmed/32027796
http://dx.doi.org/10.5853/jos.2019.02551

Ejemplares similares